CVAT · Cavitation Technologies, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0K | $0 | $3.0K | $76.0K | $122.0K | $0 | $192.0K | $519.0K | $0 | $58.0K |
| Cost of Revenue | $0 | $0 | - | $13.0K | $25.0K | - | $34.0K | $7.0K | $0 | $13.0K |
| Gross Profit | $3.0K | $0 | - | $63.0K | $97.0K | - | $158.0K | $512.0K | $0 | $45.0K |
| R&D | - | $4.0K | $7.0K | $16.0K | $42.0K | $8.0K | $0 | $9.0K | $0 | $0 |
| SG&A | $234.0K | $470.0K | $245.0K | $346.0K | $283.0K | $218.0K | $172.0K | $170.0K | $214.0K | $332.0K |
| Total Operating Expenses | $234.0K | $474.0K | $226.0K | $362.0K | $325.0K | - | $172.0K | $179.0K | $265.0K | $332.0K |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | ($231.0K) | ($474.0K) | ($249.0K) | ($299.0K) | ($228.0K) | ($226.0K) | ($14.0K) | $333.0K | ($250.0K) | ($287.0K) |
| Interest Expense | $2.0K | $2.0K | $1.0K | $2.0K | $2.0K | $1.0K | $2.0K | $2.0K | $1.0K | $1.0K |
| Income Tax | - | - | - | - | - | - | - | $0 | - | - |
| Net Income | ($219.0K) | ($476.0K) | ($258.0K) | $579.0K | ($230.0K) | ($227.0K) | ($16.0K) | $331.0K | ($251.0K) | ($299.0K) |
| EPS - Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS - Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.0K | $31.0K | $30.0K | $249.0K | $432.0K | $2.0K | $179.0K | $183.0K | $140.0K | $18.0K |
| Accounts Receivable | $3.0K | $0 | $5.0K | $10.0K | $0 | - | - | $19.0K | - | $0 |
| Inventory | - | - | - | $0 | - | - | - | - | - | $0 |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $55.0K | $44.0K | $49.0K | $286.0K | $565.0K | $42.0K | $195.0K | $204.0K | $140.0K | $18.0K |
| Total Assets | $66.0K | $55.0K | $60.0K | $297.0K | $576.0K | $77.0K | $248.0K | $275.0K | $247.0K | $143.0K |
| Current Liabilities | $383.0K | $153.0K | $99.0K | $102.0K | $150.0K | $656.0K | $598.0K | $985.0K | $1.24M | $864.0K |
| Long-term Debt | $150.0K | $150.0K | $150.0K | $126.0K | $127.0K | $128.0K | $130.0K | - | - | $145.0K |
| Total Liabilities | $533.0K | $303.0K | $249.0K | $228.0K | $277.0K | $784.0K | $728.0K | $1.13M | $1.42M | $1.06M |
| Stockholders' Equity | ($467.0K) | ($248.0K) | ($189.0K) | $69.0K | $299.0K | ($707.0K) | ($480.0K) | ($855.0K) | ($1.17M) | ($919.0K) |
| Retained Earnings | ($27.91M) | ($27.69M) | ($27.22M) | ($26.96M) | ($26.73M) | ($27.07M) | ($26.85M) | ($27.22M) | ($27.54M) | ($27.29M) |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($219.0K) | - | - | ($175.0K) | - | - | $122.0K | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | $0 | - | - | $0 | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 100.0% | - | - | 82.9% | 79.5% | - | 82.3% | 98.7% | - | 77.6% |
| Operating margin | -7700.0% | - | -8300.0% | -393.4% | -186.9% | - | -7.3% | 64.2% | - | -494.8% |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | -7300.0% | - | -8600.0% | 761.8% | -188.5% | - | -8.3% | 63.8% | - | -515.5% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | 233.3% | 21.1% | 34.4% | - | 0.0% | 1.7% | - | 0.0% |
| SG&A / Revenue | 7800.0% | - | 8166.7% | 455.3% | 232.0% | - | 89.6% | 32.8% | - | 572.4% |
| Effective tax rate | - | - | - | - | - | - | - | 0.0% | - | - |
| Return on assets | -331.8% | -865.5% | -430.0% | 194.9% | -39.9% | -294.8% | -6.5% | 120.4% | -101.6% | -209.1% |
| Return on equity | 46.9% | 191.9% | 136.5% | 839.1% | -76.9% | 32.1% | 3.3% | -38.7% | 21.5% | 32.5% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.14 | 0.29 | 0.49 | 2.80 | 3.77 | 0.06 | 0.33 | 0.21 | 0.11 | 0.02 |
| Quick ratio | 0.14 | 0.29 | 0.49 | 2.80 | 3.77 | 0.06 | 0.33 | 0.21 | 0.11 | 0.02 |
| Cash ratio | 0.12 | 0.20 | 0.30 | 2.44 | 2.88 | 0.00 | 0.30 | 0.19 | 0.11 | 0.02 |
| Leverage | ||||||||||
| Debt / Equity | -0.32 | -0.60 | -0.79 | 1.83 | 0.42 | -0.18 | -0.27 | - | - | -0.16 |
| Debt / Assets | 2.27 | 2.73 | 2.50 | 0.42 | 0.22 | 1.66 | 0.52 | - | - | 1.01 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -115.5x | -237.0x | -249.0x | -149.5x | -114.0x | -226.0x | -7.0x | 166.5x | -250.0x | -287.0x |
| Equity multiplier | -0.14 | -0.22 | -0.32 | 4.30 | 1.93 | -0.11 | -0.52 | -0.32 | -0.21 | -0.16 |
| Liabilities / Assets | 8.08 | 5.51 | 4.15 | 0.77 | 0.48 | 10.18 | 2.94 | 4.11 | 5.74 | 7.43 |
| Efficiency | ||||||||||
| Asset turnover | 0.05 | 0.00 | 0.05 | 0.26 | 0.21 | 0.00 | 0.77 | 1.89 | 0.00 | 0.41 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 365d | - | 608d | 48d | 0d | - | - | 13d | - | 0d |
| Days inventory outstanding | - | - | - | 0d | - | - | - | - | - | 0d |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | 82.4x | 28.7x | - | - | - | - | - |
| P / S | 3097.2x | - | 3855.4x | 74.8x | 70.4x | - | 14.8x | 11.0x | - | 95.4x |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -97.5% | -100.0% | - | -60.4% | -76.5% | - | 231.0% | 750.8% | -100.0% | -48.7% |
| Revenue CAGR (3y) | -63.4% | - | -77.4% | -12.4% | 47.5% | - | 38.7% | 23.7% | - | 32.4% |
| Revenue CAGR (5y) | -59.5% | - | -62.7% | 24.9% | -14.9% | - | -11.5% | 15.5% | - | -29.7% |
| Gross profit growth (YoY) | -96.9% | - | - | -60.1% | -81.1% | - | 251.1% | 924.0% | - | -59.1% |
| Operating income growth (YoY) | -1.3% | -58.5% | -10.2% | -2035.7% | - | 9.6% | 95.1% | - | -363.0% | 34.5% |
| Net income growth (YoY) | 4.8% | - | -13.7% | - | - | 9.6% | 94.6% | - | -243.8% | 31.9% |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | 73.3% | - | - | 39.6% | 47.8% | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-06-30.
Product / service
$701.0K totalLicensing Revenue$498.0K · 71.0%
Nano Reactors$203.0K · 29.0%
Peer comparison
Same SIC group: Agricultural Services
Comparing Cavitation Technologies against the 5 most active filers in the same SIC group.